Related Experiment Video
Updated: Jun 6, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Molecular identification and antifungal susceptibility profile of rare and emerging yeast species causing
Ahmad Jabrodini1,2, Esmaeel Eghtedarnejad1, Amirmahdi Ghanbarzadeh1
1Department of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Objectives:
Onychomycosis is a nail infection caused by various fungal agents. In recent years, there has been an increase in cases of onychomycosis caused by rare fungi, which are often challenging to identify using conventional methods. Sometimes, these unusual species exhibit different antifungal susceptibility patterns compared to more common yeast species. Therefore, this study aimed to identify rare yeast species causing onychomycosis and assess their antifungal susceptibility profiles.
Results:
Nineteen rare and emerging yeast isolates, representing seven species, including Candida orthopsilosis (n = 9, 47.36%), Clavispora lusitaniae (formerly Candida lusitaniae) (n = 2, 10.52%), Wickerhamiella pararugosa (formerly Candida pararugosa) (n = 2, 10.52%), Naganishia diffluens (formerly Cryptococcus diffluens) (n = 2, 10.52%), Wickerhamomyces anomalus (n = 2, 10.52%), Cyberlindnera fabianii (n = 1, 5.26%), and Meyerozyma caribbica (formerly Candida fermentati) (n = 1, 5.26%), were identified. Most rare yeast agents exhibited high minimum inhibitory concentration (MIC) values for fluconazole.
Insights
Rare yeasts are increasingly causing onychomycosis, a challenging nail infection. This study identified seven rare yeast species and found most showed high fluconazole resistance, impacting treatment options for nail fungal infections.
Area of Science:
- Medical Mycology
- Dermatology
- Infectious Diseases
Background:
- Onychomycosis (nail infection) is rising, with more cases caused by rare fungi.
- Identifying these rare fungi and their antifungal resistance is crucial for effective treatment.
- Unusual yeast species may display distinct antifungal susceptibility compared to common ones.
Purpose of the Study:
- To identify rare yeast species responsible for onychomycosis.
- To determine the antifungal susceptibility profiles of these identified rare yeasts.
Main Methods:
- Isolation and identification of nineteen rare and emerging yeast strains from onychomycosis cases.
- Seven distinct yeast species were identified, including Candida orthopsilosis and Clavispora lusitaniae.
- Antifungal susceptibility testing was performed, focusing on minimum inhibitory concentration (MIC) values.
Main Results:
- Nineteen rare yeast isolates from seven species were identified: Candida orthopsilosis (47.36%), Clavispora lusitaniae (10.52%), Wickerhamiella pararugosa (10.52%), Naganishia diffluens (10.52%), Wickerhamomyces anomalus (10.52%), Cyberlindnera fabianii (5.26%), and Meyerozyma caribbica (5.26%).
- The majority of these rare yeast isolates demonstrated high minimum inhibitory concentration (MIC) values for fluconazole.
- This suggests potential resistance to a common antifungal medication.
Conclusions:
- Rare yeast species are significant agents of onychomycosis.
- Fluconazole resistance is a concern among these emerging fungal pathogens.
- Further research into effective treatments for onychomycosis caused by rare yeasts is warranted.
More Related Videos
Related Concept Videos
Modern Molecular Taxonomy
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Candidiasis
Antifungal Agents

